Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Screening for hepatocellular carcinoma].

N Leone1, M Rizzetto

  • 1U.O.A. Gastroepatologia, Ospedale Molinette, Torino, Italy. leone.nic@tiscalinet.it

Minerva Medica
|September 21, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laparoscopic versus robot-assisted left hemicolectomy: A pilot study on sustainability.

Techniques in coloproctology·2025
Same author

Feasibility and impact of sentinel lymph node biopsy in patients affected by ano-rectal melanoma.

Techniques in coloproctology·2025
Same author

Small-scale screening of novel biobased monomers: the curious case of 1,3-cyclopentanediol.

RSC advances·2022
Same author

Domestic trauma with penile and scrotum skin degloving and testicular avulsion.

Journal of surgical case reports·2021
Same author

Treatment of hepatitis D: an unmet medical need.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Letter: HBsAg kinetics-guided interferon therapy for chronic hepatitis D - authors' reply.

Alimentary pharmacology & therapeutics·2017
Same journal

How to become a centenarian in four weeks?. Myths and limits of longevity recipes: a critical review.

Minerva medica·2026
Same journal

Comparative efficacy and safety between intravenous recombinant human prourokinase and alteplase in acute ischemic stroke treatment: a meta-analysis of randomized controlled trials.

Minerva medica·2026
Same journal

Efficacy and safety of oral tapentadol for cancer-related pain: an updated systematic review and meta-analysis.

Minerva medica·2026
Same journal

Use of the neurostimulator in thyroidectomy procedures: comparison between vagal and recurrent laryngeal nerve stimulation.

Minerva medica·2026
Same journal

Iron deficiency and risk of acute kidney injury after TAVI: a machine learning analysis.

Minerva medica·2026
Same journal

Therapeutic adherence and health literacy: a perfect match in dyslipidemic patients.

Minerva medica·2026
See all related articles

Early detection of hepatocellular carcinoma (HCC) in cirrhotic patients is crucial. Combining alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) improves HCC diagnosis sensitivity, potentially reducing invasive procedures.

Area of Science:

  • Hepatology
  • Oncology
  • Biomarker Discovery

Context:

  • Hepatocellular carcinoma (HCC) is a global health concern, particularly prevalent in cirrhotic patients.
  • The incidence rate in Europe is 3% among cirrhotic individuals, with an overall survival of 20-30 months.
  • Early detection is critical for improving patient outcomes, influenced by tumor stage and liver function.

Purpose:

  • To review current serological, urinary, and radiological markers for early HCC detection.
  • To highlight recommended screening protocols for high-risk populations.
  • To evaluate the diagnostic efficacy of combined biomarkers.

Summary:

  • Current guidelines recommend 6-month screening for cirrhotic patients and hepatitis B virus carriers over 35 using alpha-fetoprotein (AFP) and liver ultrasound (US).

Related Experiment Videos

  • The combined determination of des-gamma-carboxy prothrombin (DCP) and AFP enhances diagnostic sensitivity for HCC.
  • This combined approach shows a 23% increase in sensitivity, potentially avoiding invasive diagnostic procedures.

    • Impact:

    • Improved early detection rates for hepatocellular carcinoma.
    • Potential reduction in the need for invasive diagnostic procedures.
    • Enhanced screening strategies for high-risk populations, leading to better prognoses.